News and Comments

Halozyme's PEGPH20 Trial Results Are Worth Appreciating Not Doubting

  Friday, January 06, 2017

Extremely important, not just exciting, were the results of Halozyme Therapeutics’s (HALO) Phase 2 randomized, multi-center clinical trial of its PEGPH20 in combination with ABRAXANE® (nab-paclitaxel) and gemcitabine in stage IV pancreas cancer.  More...

HALOZYME: FINANCING PEGPH20 IS WORTH RAISING MONEY

  Wednesday, February 05, 2014

Halozyme Therapeutics (HALO) stock has been a loser yesterday while other biotech firms have rebounded after dipping during the few days’ of an angry market. The reason for the stock decline was the announcement of pricing of Halozyme’s previously announced underwritten public offering of 7,692,307 shares of its common stock at a public offering price of $13.00 per share.  More...


Recent Postings


Archive


Tags

Revlimid (lenolidamide) SYNTA (SNTA) Exelixis (EXEL) ARGOS (ARGS) Ocular Therapeutix (OCUL) Velcade (bortezomib) Micromet (MITI) CRISPR Therapeutics (CRSP) Ziofpharm (ZIOP) Roche (ROCHE) Incyte (INCY) PTC Therapeutics (PTCT) ADVENTRIX (ANX) PORTOLA (PTLA) REGULUS (RGLS) INNOVIVA (INVA) IDERA (IDRA) Aimmune Therapeutics (AIMT) HALOZYME (HALO) ZALTRAP™ Benlysta (belimumab) KERYX (KERX) Intercept (ICPT) CEMPRA (CEMP) Trastuzumab-DM1 AstraZeneca (AZN) Multiple Myeloma Sanofi (SNY) RenenxBio (RGNX) OncoCyte (OCX) GUARDIAN HEALTH ABBVIE (ABBV) CompuGen (CGEN) GlaxoSmithKline (GSK) Sarepta (SRPT) Biogen Idec (BIIB) Cytokinetics (CYTK) SERES THERAPEUTICS (MCRB) Endometrial Cancer NOVOCURE (NVCR) Idenix (IDIX) Theravance (THRX) Galena (GALE) Inovio (INO) NANTKWEST (NK) Dynavax (DVAX) KITE (KITE) Adaptimmune (ADAP) JUNO (JUNO) Prosensa (RNA) Sangamo (SGMO) Bristol-Myers Squibb (BMY) Vitae Pharmaceuticals (VTAE) Rapamune Dendreon (DNDN) Biocryst (BCRX) LEXICON (LXRX) MODERNA ImmunoGen (IMGN) TOKAI (TKAOI) Intermune (ITMN) Seattle Genetics (SGEN) Ridaforolimus Human Longevity (HLI) Sanofi-Aventis (SAN) Agenus (AGEN) Elan (ELN) ACADIA (ACAD) VANDA (VNDA) NEUROCRINE (NBIX) Spike Therapeutics (ONCE) Bellicum (BLCM) Telaprevir ARCA (ABIO) Pluristem (PSTI) Prolor Biotech (PBTH) galapagos (GLPG) BIOMARIN (BMRN) Human Genome Sciences (HGSI) ISIS (ISIS) Sanofi (SNA) Herceptin Intrexon (XON) C4 Therapeutics Sequenom (SQNM) Illumina (ILMN) Alnylam (ALNY) Amgen (AMGN) NEKTAR (NKTR)) Gilead (GILD) Abbott Laboratories (ABT) Roche (RHHBY) Valeant Pharmaceuticals International (VRX) Genentech Editas (EDIT) Anadys (ANDS) Tysabri JOUNCE THERAPEUTICS (JNCE) Ariad (ARIA) Zerenex Advaxis (ADXS) Jazz Pharmaceuticals (JAZZ) Onyx (ONXX) Regeneron (REGN) Vertex (VRTX) Mirati Therapeutics (MRTX) Agenus (AGEN Global Cell Therapeutics (GBT) Ionis (IONS) OSI (OSIP) Xoma (XOMA) Array Pharmaceuticals (ARRY) SUNESIS PHARMACEUTICALS (SNSS) Theravance Bio Pharma (TBPH) Merck (MRK) Anacor (ANAC) AERIE PHARMACEUTICALS Alder Biopharmaceuticals (ALDR) Auspex (ASPX) AGOS (ARGS)